Cordyceps Research: What Does the Evidence Show?

Cordyceps attracts some of the boldest claims of any mushroom. This article explains where Cordyceps research came from, which species and materials have been studied, looks at each of the main human trials and who funded them, and sets out what can reasonably be concluded.

Cordyceps Research: What Does the Evidence Show?

Key takeaways

  • Cordyceps research spans several species and preparations.
  • Much of it is laboratory or animal work; human studies are few and small.
  • Different materials make results hard to compare.
  • The evidence doesn’t support specific claims about effects in people.

Cordyceps is marketed with some of the boldest claims in the functional mushroom world. This article takes a careful look at the research: where it came from, which fungi have actually been studied, what the human trials found and didn’t find, who funded them, and what can reasonably be concluded.

A short history of Cordyceps research

The story begins on the Tibetan Plateau with Ophiocordyceps sinensis, the caterpillar fungus known in Tibetan as yartsa gunbu, “summer grass, winter worm”. It grows from the larvae of ghost moths buried in high-altitude meadows, and it appears in Tibetan and Chinese botanical writing over several centuries. See Cordyceps Through History.

Laboratory interest took a different route. In 1950, researchers isolated a compound they named cordycepin from Cordyceps militaris, the bright orange species that also grows wild in Britain. Cordycepin’s unusual chemistry made it a long-running subject of laboratory study. See Cordycepin Explained.

Western attention arrived in 1993, when a group of Chinese distance runners broke several world records and their coach credited, among other things, a tonic containing Cordyceps. The team was later overshadowed by doping controversies, but the story stuck, and Cordyceps became linked with sport in the popular imagination. Because wild O. sinensis was scarce and extremely expensive, Chinese researchers developed a fermented mycelium strain known as Cs-4 as a substitute. Much of the human research uses Cs-4, and later work has questioned whether it is the same species at all.

A complicated picture: which Cordyceps?

Studies described as “Cordyceps research” have used:

  • wild Ophiocordyceps sinensis;
  • fermented mycelium strains such as Cs-4, often labelled Cordyceps sinensis;
  • cultivated Cordyceps militaris fruiting bodies or extracts;
  • multi-ingredient blends that include Cordyceps alongside other substances;
  • purified cordycepin.

These are different materials with different chemistry, and a result from one cannot simply be transferred to another. See Cordyceps militaris vs Ophiocordyceps sinensis and Cordyceps Compounds and Chemistry Explained.

The three tiers of evidence

See In Vitro, Animal and Human Studies for a full explanation of why each matters.

Laboratory (in vitro) studies

Laboratory studies, particularly of purified cordycepin, are numerous. They apply compounds directly to cells, often at concentrations that could not be reached in the body, and without digestion, absorption or metabolism. Cordycepin is also broken down rapidly in the body, which makes laboratory results especially hard to translate.

Animal studies

Animal studies have tested extracts and compounds, mostly in rodents, often at amounts and in forms unlike human use.

Human studies

Human trials are relatively few, generally small and short, and use varied preparations. The main placebo-controlled trials are summarised below.

The human studies, one by one

Parcell et al., 2004 (USA). Twenty-two endurance-trained male cyclists took 3 g a day of a Cs-4 product (CordyMax) or placebo for five weeks. The researchers found no effect on aerobic capacity, ventilatory threshold or time-trial performance.

Earnest et al., 2004 (USA). Seventeen amateur cyclists took a commercial formula for two weeks. As well as Cs-4, it contained Rhodiola root extract and several other ingredients. The researchers found no significant difference from placebo on any of the performance measures. Because the product combined several ingredients, it couldn’t have isolated Cordyceps anyway.

Chen et al., 2010 (USA). A double-blind, placebo-controlled pilot trial of 20 healthy adults aged 50 to 75, who took Cs-4 capsules or placebo three times a day for 12 weeks. The researchers reported changes in two exercise-test thresholds in the Cs-4 group but not the placebo group, while maximum oxygen uptake did not change in either group. With ten people per group, this is a pilot, not a definitive result.

Kang et al., 2015 (Korea). One of the few trials of Cordyceps militaris itself. Seventy-nine healthy men took 1.5 g a day of an ethanol-treated C. militaris preparation or placebo for four weeks, and researchers measured a range of immune markers in their blood. They reported differences from placebo on several laboratory markers and no significant adverse reactions. Laboratory markers in blood are not the same as real-world outcomes, the study included only men, and it lasted four weeks, limitations the researchers themselves acknowledged.

Hirsch et al., 2017 (USA). Twenty-eight young adults took a mushroom blend containing Cordyceps militaris or placebo. After one week there was no significant difference in performance. Ten participants volunteered to continue for two more weeks, and in that small group the researchers reported changes in maximal oxygen consumption. The study was funded by the company that owns the blend’s trademark, it tested a blend rather than Cordyceps alone, and the positive results came from a sub-group of ten people.

Reading the human studies together

  • Most trials didn’t test Cordyceps militaris. The majority used the Cs-4 fermented mycelium, and results from it can’t be assumed to apply to C. militaris fruiting bodies.
  • They are small. Group sizes of ten to twenty are prone to chance findings.
  • Blends muddy the picture. Several products combined Cordyceps with other active ingredients.
  • Results are mixed. The better-controlled exercise studies in trained athletes found no effect, while positive findings came from pilots and sub-groups.
  • Industry involvement. Several trials were funded or supplied by ingredient companies.
  • Markers aren’t outcomes. Changes in laboratory measurements don’t necessarily mean any difference people would notice.
  • No large trials. There is not yet a large, independent, long-term trial of a standardised Cordyceps militaris product.

Safety

The human trials above generally reported Cordyceps preparations as well tolerated over the short periods studied. Longer-term safety has been less well studied. Anyone with a mushroom allergy should avoid Cordyceps. If you are pregnant, breastfeeding, taking medication or managing a health condition, speak to your GP or pharmacist before taking any mushroom supplement. Tinctures also contain alcohol.

What we can reasonably conclude

Cordyceps is an active research area with a colourful history and genuinely unusual chemistry. But the human evidence is small, mixed and mostly based on materials other than Cordyceps militaris. It doesn’t support specific claims about what Cordyceps products do in people, and no health claims are authorised for Cordyceps in the UK.

What remains uncertain

  • Which species, preparations and compounds, if any, have meaningful effects in people.
  • Whether results from Cs-4 mycelium apply to Cordyceps militaris fruiting bodies.
  • What amounts, if any, would be relevant.
  • Whether small positive findings would hold up in larger, independent trials.

What better evidence would look like

Larger, longer, pre-registered trials of a clearly identified and standardised Cordyceps militaris material, run independently of manufacturers and measuring outcomes that matter to people rather than laboratory markers alone. Until then, the honest answer is: intriguing, but unproven.

Our approach

Our Cordyceps militaris is cultivated by a specialist UK grower, and we make our tincture from its fruiting bodies in small batches in Dorset. We describe it by what it is and how it’s made, not by what it might do. For the wider picture, see The Complete Guide to Cordyceps and How Cultivated Cordyceps Is Grown.

References

  1. Parcell AC, et al. Cordyceps sinensis (CordyMax Cs-4) supplementation does not improve endurance exercise performance. International Journal of Sport Nutrition and Exercise Metabolism. 2004;14(2):236–242.
  2. Earnest CP, et al. Effects of a commercial herbal-based formula on exercise performance in cyclists. Medicine and Science in Sports and Exercise. 2004;36(3):504–509.
  3. Chen S, et al. Effect of Cs-4 (Cordyceps sinensis) on exercise performance in healthy older subjects: a double-blind, placebo-controlled trial. Journal of Alternative and Complementary Medicine. 2010;16(5):585–590.
  4. Kang HJ, et al. Cordyceps militaris enhances cell-mediated immunity in healthy Korean men. Journal of Medicinal Food. 2015;18(10):1164–1172.
  5. Hirsch KR, et al. Cordyceps militaris improves tolerance to high-intensity exercise after acute and chronic supplementation. Journal of Dietary Supplements. 2017;14(1):42–53.

Study titles are reproduced as published and are not claims made by Spore & Bloom.

Last reviewed . How we research and write

Join the Spore & Bloom Journal

Receive occasional notes on mushrooms, botanical extraction, new releases and events.

We write occasionally and never share your address. Unsubscribe at any time.